Blogs
4 considerations for navigating ‘innovation antibodies’ and ‘innovation theater’
Many innovation leaders need to carefully navigate the waters between too much resistance to innovation from corporate antibodies and, conversely, too much enthusiasm for innovation from those wishing to put on theater.
BlogsHow the American Cancer Society is navigating its digital transformation journeycio.com
BlogsMicro and macro agents: The emerging architecture of the agentic enterprisecio.com
BlogsHow DevOps changes the delivery of IT functionscio.com
BlogsAGI skepticism: Tellers vs. toll booth workerscio.com
Blogs5 critical roles for CIOs in defining digital strategy and executing digital transformation programscio.com
Blogs7 key factors of successful digital transformationcio.com
Events2026 Cloud Security Trends: Closing the Cloud Complexity GapBrightTALK
EventsCisco Enterprise Networking Innovation ShowcaseCisco
EventsCisco and McLaren Racing: Innovation at Full SpeedCisco
ResourcesData Importduckdb.org
ResourcesData Importduckdb.org
ResourcesData Importduckdb.org
ResourcesData Importduckdb.org
ResourcesData Importduckdb.org
ResourcesData Importduckdb.org
ResourcesData Importduckdb.org
ResourcesData Importduckdb.org
ShoppingInnovationsxsw.com
BlogsNavigating Regional Network Blockssupabase.com
BlogsRuntime-Extensible SQL Parsers Using PEGduckdb.org